Commodore Capital Lp - Feb 23, 2023 Form 3 Insider Report for Ambrx Biopharma Inc. (AMAM)

Role
10%+ Owner
Signature
/s/ Michael Kramarz, Managing Partner
Stock symbol
AMAM
Transactions as of
Feb 23, 2023
Transactions value $
$0
Form type
3
Date filed
3/3/2023, 03:05 PM
Previous filing
Feb 23, 2023
Next filing
Jun 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AMAM Ordinary Shares 35.7M Feb 23, 2023 By Commodore Capital Master LP F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The ordinary shares of the Issuer, par value $0.0001 per share (the "Ordinary Shares") may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares.
F2 As of February 23, 2023, the Reporting Person owns 5,100,000 ADSs, representing 35,700,000 Ordinary Shares.
F3 The securities are held directly by Commodore Capital Master LP ("Commodore Master"). Commodore Capital LP ("Commodore Capital") is the investment manager to Commodore Master. Michael Kramarz and Robert Egen Atkinson are the managing partners of Commodore Capital and exercise investment and dispositive power over the securities held by Commodore Master. Each of Commodore Capital, Dr. Kramarz and Dr. Atkinson disclaim beneficial ownership of such securities, except to the extent of their pecuniary interest therein. This report shall not be deemed an admission that Commodore Capital, Commodore Master, Dr. Kramarz and Dr. Atkinson or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.